Works in Diabetes Therapy, 2023, Vol 14, Issue 1

Results: 16

Treatment of the New Era: Long-Term Ticagrelor Monotherapy for the Treatment of Patients with Type 2 Diabetes Mellitus following Percutaneous Coronary Intervention: A Meta-analysis.

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 47, doi. 10.1007/s13300-022-01350-9

By:

Wang, Hong;
Xie, Xiaoya;
Zu, Quannan;
Lu, Ming;
Chen, Rongfa;
Yang, Zhiren;
Gao, Yongqiang;
Tang, Zhangui

Publication type:

Article

Single-Field Fundus Photography for Screening of Diabetic Retinopathy: The Prevalence and Associated Factors in a Population-Based Study.

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 205, doi. 10.1007/s13300-022-01348-3

By:

Soleimani, Mohammadreza;
Alipour, Fateme;
Taghavi, Yousef;
Fatemipour, Marjan;
Hakimi, Hamid;
Jamali, Zahra;
Khalili, Parvin;
Ayoobi, Fatemeh;
Sheikh, Maryam;
Tavakoli, Roya;
Zand, Amin

Publication type:

Article

Sustained Improvement in Glycemic Control in Emerging Adults with Type 1 Diabetes 2 Years After the Start of the COVID-19 Pandemic.

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 153, doi. 10.1007/s13300-022-01346-5

By:

Swaich, Harshpreet;
Advani, Andrew

Publication type:

Article

An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes.

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 123, doi. 10.1007/s13300-022-01344-7

By:

Lingvay, Ildiko;
Catarig, Andrei-Mircea;
Lawson, Jack;
Chubb, Barrie;
Gorst-Rasmussen, Anders;
Evans, Lyndon Marc

Publication type:

Article

Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Hypertensive and/or Diabetic People Aged over 60 Years: A Prospective Open-Label Study.

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 139, doi. 10.1007/s13300-022-01343-8

By:

Huang, Rongdong;
Liu, Xiaoqin;
Xie, Fangqin;
Li, Junrong;
Tang, Zhangbin;
Wu, Yuying;
Zhou, Peicong;
Zhang, Dongjuan

Publication type:

Article

Risk Factors for Glycemic Control in Hospitalized Patients with Type 2 Diabetes Receiving Continuous Subcutaneous Insulin Infusion Therapy.

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 167, doi. 10.1007/s13300-022-01342-9

By:

Wang, Shun-hua;
Shao, Wei;
Jiang, Qiu-hui;
Zheng, Xuan-ling;
Shen, Qing-bao;
Lin, Xiao-yan;
Zhang, Qiao-qing;
Zhang, Lu-lu;
Shi, Xiu-lin;
Wang, Wen-gui;
Li, Xue-jun

Publication type:

Article

Why Do So Many People with Type 2 Diabetes Who Take Insulin Have Lipohypertrophy? Fate or Educational Deficiencies?

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 179, doi. 10.1007/s13300-022-01341-w

By:

Gentile, Sandro;
Guarino, Giuseppina;
Della Corte, Teresa;
Marino, Giampiero;
Satta, Ersilia;
Pasquarella, Maria;
Romano, Carmine;
Alfarone, Carmelo;
Giordano, Laura;
Loiacono, Fabrizio;
Capece, Maurizio;
Lamberti, Rossella;
Strollo, Felice

Publication type:

Article

Recommendations for Early and Comprehensive Management of Type 2 Diabetes and Its Related Cardio-Renal Complications.

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 11, doi. 10.1007/s13300-022-01340-x

By:

Abu-Alfa, Ali K.;
Atallah, Paola J.;
Azar, Sami T.;
Dagher, Elissar C.;
Echtay, Akram S.;
El-Amm, Mireille A.;
Hazkial, Habib G.;
Kassab, Roland Y.;
Medlej, Rita C.;
Mohamad, Malek A.

Publication type:

Article

Therapeutic Effects of Switching to Anagliptin from Other DPP-4 Inhibitors in T2DM Patients with Inadequate Glycemic Control: A Non-interventional, Single-Arm, Open-Label, Multicenter Observational Study.

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 109, doi. 10.1007/s13300-022-01339-4

By:

Kim, Sang-Yong;
Kim, Sungrae

Publication type:

Article

COVID-19 Vaccination and Diabetes Mellitus: How Much Has It Made a Difference to Outcomes Following Confirmed COVID-19 Infection?

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 193, doi. 10.1007/s13300-022-01338-5

By:

Heald, Adrian H.;
Jenkins, David A.;
Williams, Richard;
Mudaliar, Rajshekhar N.;
Naseem, Asma;
Davies, Kelly A. Bowden;
Gibson, J. Martin;
Peng, Yonghong;
Ollier, William

Publication type:

Article

Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China.

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 93, doi. 10.1007/s13300-022-01336-7

By:

Liu, Lei;
Ruan, Zhen;
Ung, Carolina Oi Lam;
Zhang, Yawen;
Shen, Yang;
Han, Sheng;
Jia, Ruxu;
Qiao, Jingtao;
Hu, Hao;
Guo, Lixin

Publication type:

Article

Use of iGlarLixi for Management of Type 2 Diabetes in Japanese Clinical Practice: SPARTA Japan, a Retrospective Observational Study.

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 219, doi. 10.1007/s13300-022-01333-w

By:

Matsuhisa, Munehide;
Miyoshi, Hideaki;
Yabe, Daisuke;
Takahashi, Yoko;
Morimoto, Yukiko;
Terauchi, Yasuo

Publication type:

Article

Addendum 1: Forum for Injection Technique and Therapy Expert Recommendations, India.

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 29, doi. 10.1007/s13300-022-01332-x

By:

Kalra, Sanjay;
Unnikrishnan, Ambika G.;
Prasanna Kumar, K. M.;
Sahay, Rakesh;
Chandalia, Hemraj B.;
Saboo, Banshi;
Annamalai, Sundaram;
Kesavadev, Jothydev;
Shukla, Rishi;
Wangnoo, S. K.;
Baruah, Manash P.;
Jacob, Jubbin;
Arora, Saurabh;
Singla, Rajiv;
Sharma, Suresh K.;
Damodaran, Suresh;
Bantwal, Ganapathi

Publication type:

Article

Diabetes Therapy Podcast: Real-World Data for Glucose Sensing Technologies in Type 1 Diabetes.

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 1, doi. 10.1007/s13300-022-01331-y

By:

Oliver, Nick

Publication type:

Article

Spatial Patterns and Determinants of Diabetes Mellitus in Indian Adult Population: a Secondary Data Analysis from Nationally Representative Surveys.

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 63, doi. 10.1007/s13300-022-01329-6

By:

Krishnamoorthy, Yuvaraj;
Rajaa, Sathish;
Verma, Madhur;
Kakkar, Rakesh;
Kalra, Sanjay

Publication type:

Article

Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study.

Published in:

Diabetes Therapy, 2023, v. 14, n. 1, p. 77, doi. 10.1007/s13300-022-01328-7

By:

Candido, Riccardo;
Modugno, Monica;
Larosa, Monica;
Rossi, Maria Chiara;
Nicolucci, Antonio;
Gabellieri, Enrico

Publication type:

Article